Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 May 1;9(5):465-474.
doi: 10.2217/fvl.14.28.

Animal models of HIV peripheral neuropathy

Tricia H Burdo  1 , Andrew D Miller  2
Affiliations

Animal models of HIV peripheral neuropathy

Tricia H Burdo et al. Future Virol. .

Abstract

The use of animal models in the study of HIV and AIDS has advanced our understanding of the underlying pathophysiologic mechanisms of infection. Of the multitude of HIV disease manifestations, peripheral neuropathy remains one of the most common long-term side effects. Several of the most important causes of peripheral neuropathy in AIDS patients include direct association with HIV infection with or without antiretroviral medication and infection with opportunistic agents. Because the pathogeneses of these diseases are difficult to study in human patients, animal models have allowed for significant advancement in the understanding of the role of viral infection and the immune system in disease genesis. This review focuses on rodent, rabbit, feline and rhesus models used to study HIV-associated peripheral neuropathies, focusing specifically on sensory neuropathy and antiretroviral-associated neuropathies.

Keywords: HIV neuropathy; HIV-1; acquired immunodeficiency syndrome; animal models; antiretroviral agents; macrophage; peripheral nervous system diseases; sensory neuropathy.

PubMed Disclaimer

References

    1. Ferrari S, Vento S, Monaco S, et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc. 2006;81(2):213–219. - PubMed
    1. Simpson DM. Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy. J Neurovirol. 2002;8(Suppl. 2):33–41. - PubMed
    1. Ellis RJ, Rosario D, Clifford DB, et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch Neurol. 2010;67(5):552–558. Provides updated estimates of the prevalence and clinical impact of HIV associated sensory neuropathy (HIV-SN) and neuropathic pain due to HIV-SN in the era of antiretroviral therapy (ART) - PMC - PubMed
    1. Ghosh S, Chandran A, Jansen JP. Epidemiology of HIV-related neuropathy: a systematic literature review. AIDS Res Hum Retroviruses. 2012;28(1):36–48. Summarizes the incidence and prevalence of neuropathy among HIV patients and subgroups using a systematic search of the literature. The prevalence of neuropathy among HIV patients derived from 25 studies varied from 1.2 to 69.4%. - PubMed
    1. Keswani SC, Polley M, Pardo CA, Griffin JW, McArthur JC, Hoke A. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons. Ann Neurol. 2003;54(3):287–296. - PubMed

LinkOut - more resources